We are live on ! Find out more
BRM

Boston Research & Management Portfolio holdings

AUM $421M
1-Year Est. Return 16.18%
This Fund
S&P 500
This Quarter Est. Return
+3.08%
1 Year Est. Return
+16.18%
3 Year Est. Return
+48.21%
5 Year Est. Return
+65.09%
10 Year Est. Return
+242.1%
AUM
$161M
AUM Growth
-$242K
Cap. Flow
-$4.42M
Cap. Flow %
-2.75%
Top 10 Hldgs %
23.64%
Holding
98
New
Increased
36
Reduced
27
Closed
4

Sector Composition

Rank Sector Weight
1 Industrials 16.6%
2 Technology 12.65%
3 Financials 11.19%
4 Healthcare 10.82%
5 Consumer Staples 10.35%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MSFT icon
1
Microsoft
MSFT
$2.93T
$4.72M 2.94%
85,399
-2,882
-3% -$151K
CSCO icon
2
Cisco
CSCO
$441B
$4.13M 2.57%
145,036
+1,083
+0.8% +$27.9K
GE icon
3
GE Aerospace
GE
$364B
$3.87M 2.41%
25,419
-274
-1% -$38.7K
KO icon
4
Coca-Cola
KO
$351B
$3.77M 2.35%
81,377
-1,520
-2% -$66.2K
INTC icon
5
Intel
INTC
$478B
$3.72M 2.32%
115,133
+860
+0.8% +$26.4K
PEP icon
6
PepsiCo
PEP
$187B
$3.71M 2.31%
36,211
-80
-0.2% -$7.9K
MMM icon
7
3M
MMM
$83.4B
$3.68M 2.29%
26,403
+138
+0.5% +$17.7K
XOM icon
8
ExxonMobil
XOM
$611B
$3.65M 2.28%
43,726
+1,423
+3% +$114K
MCD icon
9
McDonald's
MCD
$190B
$3.38M 2.1%
26,870
-730
-3% -$87.2K
ACN icon
10
Accenture
ACN
$87.9B
$3.33M 2.07%
28,881
-275
-0.9% -$28.2K
FAST icon
11
Fastenal
FAST
$52.2B
$3.25M 2.03%
265,480
+28,740
+12% +$312K
AAPL icon
12
Apple
AAPL
$4.9T
$3.2M 1.99%
117,548
+3,120
+3% +$77.7K
MA icon
13
Mastercard
MA
$480B
$3.19M 1.99%
33,800
+630
+2% +$55.7K
IWM icon
14
iShares Russell 2000 ETF
IWM
$82.2B
$3.15M 1.96%
28,518
-280
-1% -$29K
BRK.B icon
15
Berkshire Hathaway Class B
BRK.B
$1.06T
$3.15M 1.96%
22,201
+795
+4% +$105K
WMT icon
16
Walmart Inc
WMT
$909B
$3.13M 1.95%
136,926
+14,610
+12% +$320K
MDT icon
17
Medtronic
MDT
$106B
$2.96M 1.84%
39,464
-870
-2% -$65.5K
CHRW icon
18
C.H. Robinson
CHRW
$24.6B
$2.96M 1.84%
39,822
-30
-0.1% -$2.06K
UPS icon
19
United Parcel Service
UPS
$100B
$2.95M 1.84%
27,991
+225
+0.8% +$21.9K
CVS icon
20
CVS Health
CVS
$137B
$2.94M 1.83%
28,310
+1,900
+7% +$185K
XYL icon
21
Xylem
XYL
$29.2B
$2.91M 1.81%
71,172
+340
+0.5% +$12.5K
ABBV icon
22
AbbVie
ABBV
$450B
$2.9M 1.8%
50,749
+1,605
+3% +$89.5K
LH icon
23
Labcorp
LH
$23.2B
$2.84M 1.77%
28,193
+35
+0.1% +$3.36K
WU icon
24
Western Union
WU
$2.77B
$2.82M 1.76%
146,215
+1,310
+0.9% +$23.6K
RTX icon
25
RTX Corp
RTX
$261B
$2.81M 1.75%
44,625
+3,797
+9% +$220K

Similar funds

Boston Research & Management's Q1 2016 Portfolio in Review

As of Q1 2016, Boston Research & Management held 98 positions worth $161M, down 0.15% from $161M the previous quarter. Its ten largest holdings account for 24% of the portfolio.

Trading was light in Q1 2016: portfolio turnover was 4.1%. Boston Research & Management opened no new positions and exited 4, leaving the 98-position portfolio largely intact.

By sector, the portfolio is most concentrated in Industrials at 17% of assets, up from 16% a quarter earlier, followed by Technology and Financials.

  • Boston Research & Management added most to iShares Core MSCI Emerging Markets ETF in Q1 2016, an estimated $1.08M increase.
  • Boston Research & Management's biggest Q1 2016 reduction was iShares Core S&P 500 ETF, cutting an estimated $4.28M.
  • Boston Research & Management fully exited Clorox in Q1 2016, selling an estimated $1.88M.
  • Boston Research & Management's ten largest holdings make up 24% of its $161M portfolio in Q1 2016.
  • Boston Research & Management opened 0 new positions and closed 4 in Q1 2016.
  • Boston Research & Management's portfolio value fell 0.15% quarter-over-quarter to $161M.

Based on Boston Research & Management's 13F filing for Q1 2016, filed 13 May 2016.